Trial intelligence / Profile preview

Tomopenem in Complicated Skin or Skin Structure Infections

NCT00303589Phase 2Completed

Sponsor
Roche
Start
Dec 2005
Primary completion
Oct 2007
Modality
Small Molecules
Countries
11
01

Overview

A Phase 2 trial of tomopenem in Complicated skin and skin structure infection (cSSSI), sponsored by Roche. Started Dec 2005; status: completed.

02

Drugs

tomopenem
03

Conditions

Complicated skin and skin structure infection (cSSSI)

Beyond the preview

Go deeper on NCT00303589.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00303589.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call